![](https://investorshub.advfn.com/uicon/434605.png?cb=1493182534)
Thursday, October 12, 2017 2:57:03 AM
I believe the raise will turn out a positive IF it has been made with the right subject.
"So, right now, we have a company which will likely only have sales and hopefully earnings from ANDA's between now and late 2019 when perhaps RExista will finally start generating revenues (Mackie says not until 2020). That is a long time to wait. A Rexista approval and partnership deal with Purdue or someone else would certainly help make the wait seem shorter but there are no guarantees on either front."
they have to move on with PODRAS (and the new oxy) and REGABATIN; can Odidi still think to wait for further ANDAs approvals ? can he really ?
still puzzled why putting out Q3 earnings with all the wording concerning cash needs, Seroquel ramping up or not, etc...and then the morning after PR tha new shares issuance (which was clearly ready to 12 hours before).
There is something ODD here...or just stupid ? not sure
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM